litlas
ログインアカウント作成

James B. Bussel

1983–2025 年に発表

160
論文数
31,293
被引用数
95
h 指数
156
i10 指数

被引用数

James B. Bussel の年別被引用数1984 年: 被引用 3 件1985 年: 被引用 7 件1986 年: 被引用 3 件1987 年: 被引用 8 件1988 年: 被引用 13 件1989 年: 被引用 8 件1990 年: 被引用 8 件1991 年: 被引用 9 件1992 年: 被引用 7 件1993 年: 被引用 11 件1994 年: 被引用 4 件1995 年: 被引用 8 件1996 年: 被引用 11 件1997 年: 被引用 17 件1998 年: 被引用 14 件1999 年: 被引用 12 件2000 年: 被引用 19 件2001 年: 被引用 23 件2002 年: 被引用 30 件2003 年: 被引用 27 件2004 年: 被引用 28 件2005 年: 被引用 52 件2006 年: 被引用 68 件2007 年: 被引用 109 件2008 年: 被引用 141 件2009 年: 被引用 166 件2010 年: 被引用 170 件2011 年: 被引用 218 件2012 年: 被引用 206 件2013 年: 被引用 235 件2014 年: 被引用 205 件2015 年: 被引用 220 件2016 年: 被引用 184 件2017 年: 被引用 184 件2018 年: 被引用 194 件2019 年: 被引用 838 件2020 年: 被引用 743 件2021 年: 被引用 1,143 件2022 年: 被引用 672 件2023 年: 被引用 462 件2024 年: 被引用 754 件2025 年: 被引用 332 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,506 件、この内訳の 25.2%イギリス: 引用元論文 461 件、この内訳の 7.7%中国: 引用元論文 455 件、この内訳の 7.6%イタリア: 引用元論文 364 件、この内訳の 6.1%ドイツ: 引用元論文 333 件、この内訳の 5.6%フランス: 引用元論文 315 件、この内訳の 5.3%カナダ: 引用元論文 290 件、この内訳の 4.9%スペイン: 引用元論文 189 件、この内訳の 3.2%オランダ: 引用元論文 188 件、この内訳の 3.1%オーストラリア: 引用元論文 158 件、この内訳の 2.6%日本: 引用元論文 158 件、この内訳の 2.6%スイス: 引用元論文 130 件、この内訳の 2.2%
0%25.2%その他 23.9%

機関

分野

  • Medicine74.5%
  • Immunology and Microbiology18.2%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Neuroscience0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Chemistry0.2%
  • その他1.3%

トピック

  • Platelet Disorders and Treatments15%
  • Blood groups and transfusion9.2%
  • Heparin-Induced Thrombocytopenia and Thrombosis3.7%
  • Immunodeficiency and Autoimmune Disorders3.1%
  • T-cell and B-cell Immunology2.8%
  • Immune Cell Function and Interaction2.5%
  • その他63.7%

共著者

全論文

検索で開く
  1. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

    著者: Drew Provan, Donald M. Arnold, James B. Bussel, Beng H. Chong, Nichola Cooper, Terry Gernsheimer, Waleed Ghanima, Bertrand Godeau, Tomás José González‐López, John D. Grainger, Ming Hou, Caroline Kruse, Vickie McDonald, Marc Michel, Adrian C. Newland, Sue Pavord, Francesco Rodeghiero, Marie Scully, Yoshiaki Tomiyama, Raymond Wong, Francesco Zaja, David J. Kuter - Blood Advances 2019 被引用: 1,090

  2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    著者: Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, Marc Michel, Drew Provan, Donald M. Arnold, James B. Bussel, Douglas B. Cines, Beng H. Chong, Nichola Cooper, Bertrand Godeau, Klaus Lechner, Maria Gabriella Mazzucconi, Robert McMillan, Miguel Á. Sanz, Paul Imbach, Victor S. Blanchette, Thomas Kühne, Marco Ruggeri, James N. George - Blood 2008 被引用: 2,660

  3. International consensus report on the investigation and management of primary immune thrombocytopenia

    著者: Drew Provan, Roberto Stasi, Adrian C. Newland, Victor S. Blanchette, Paula Bolton‐Maggs, James B. Bussel, Beng H. Chong, Douglas B. Cines, Terry Gernsheimer, Bertrand Godeau, John D. Grainger, Ian Greer, Beverley J. Hunt, Paul Imbach, G. Lyons, Robert McMillan, Francesco Rodeghiero, Miguel Á. Sanz, Michael D. Tarantino, Shirley Watson, Joan Young, David J. Kuter - Blood 2009 被引用: 2,267

  4. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

    著者: James B. Bussel, Donald M. Arnold, Elliot Grossbard, Jiřı́ Mayer, Jacek Treliński, Wojciech Homenda, Andrzej Hellmann, Jerzy Windyga, Liliya Sivcheva, Alhossain A. Khalafallah, Francesco Zaja, Nichola Cooper, Vadim Markovtsov, Hany Zayed, Anne‐Marie Duliège - American Journal of Hematology 2018 被引用: 351

  5. Thrombopoietin receptor agonists: ten years later

    著者: Waleed Ghanima, Nichola Cooper, Francesco Rodeghiero, Bertrand Godeau, James B. Bussel - Haematologica 2019 被引用: 390

  6. B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

    著者: Irene Puga, Montserrat Cols, Carolina Barra, Bing He, Linda Cassis, Maurizio Gentile, Laura Comerma, Alejo Chorny, Meimei Shan, Weifeng Xu, Giuliana Magri, Daniel M. Knowles, Wayne Tam, April Chiu, James B. Bussel, Sergi Serrano, José A. Lorente, Beatríz Bellosillo, Josep Lloreta, Núria Juanpere, Francesc Alameda, Teresa Baró, Cristina Díaz de Heredia, Núria Torán, Albert Català, Montserrat Torrebadell, Clàudia Fortuny, V. Cusí, Carmen Carreras, George A. Díaz, J. Magarian Blander, Claire‐Michèle Farber, Guido Silvestri, Charlotte Cunningham‐Rundles, Michaela Calvillo, Carlo Dufour, Lucia Dora Notarangelo, Vassilios Lougaris, Alessandro Plebani, Jean‐Laurent Casanova, Stephanie Ganal, Andreas Diefenbach, Juan I. Aróstegui, Manel Juan, Jordi Yagüe, Nizar Mahlaoui, Jean Donadieu, Kang Chen, Andrea Cerutti - Nature Immunology 2011 被引用: 721

  7. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

    著者: Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, Monica Carpenedo, David J. Kuter, Hanny Al‐Samkari, James B. Bussel, Marie Godar, Jaume Ayguasanosa, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian C. Newland, Michael Fillitz, Paul Knoebl, Stef Meers, Ismail Amine, Jaromír Gumulec, Antonín Hluší, Jiřı́ Mayer, Philippe Quittet, Jean‐François Viallard, M Betaneli, I Datikashvili-David, Genadi Iosava, Levan Makhaldiani, László Rejtő, Nino Sharashenidze, Stefanie Groepper, Alexander Röth, Aryan Hamed, Árpád Illés, Monica Carpenedo, Andrea Artoni, Monica Bocchia, Barbara Gamberi, Alessandra Borchiellini, Esther Natalie Olíva, Andrea Patriarca, Simona Tomassetti, Yoshitaka Miyakawa, Kiyoshi Ando, Hiroshi Handa, Shinya Katsutani, Kaichi Nishiwaki, Shoko Ito, Tomoki� Ito, Fransien de Boer, A.J. Gerard Jansen, Hanna Ciepłuch, Szymon Fornagiel, Sebastian Grosicki, Maria Soroka‐Wojtaszko, Jacek Treliński, Б. А. Бакиров, Elena Borisenkova, Elena Volodicheva, Yuri Shatokhin, Andrey Proydakov, Maria Aranzazu Alonso, María Eva Mingot‐Castellano, Blanca Sánchez‐González, Blanca Sanchez-Gonzalez, Meltem Aylı, Tuba Hacıbekiroğlu, Ahmet Muzaffer Demir, Meliha Nalçacı, Mehmet Sönmez, Anıl Tombak, Selami Koçak Toprak, Burhan Turgut, Filiz Vural, Münci Yağcı, Fevzi Altuntaş, Mehmet Turgut, Emın Kaya, Nataliya Romanyuk, Vickie McDonald, Syed Rashid Saeed Kazmi, Catherine M. Broome, Spero R. Cataland, Ketan Doshi, Steven R. Lentz, Michael Boxer, Richard Rosenberg, Michael Boxer, Richard Rosenberg - The Lancet 2023 被引用: 91

  8. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention

    著者: Dhavalkumar D. Patel, James B. Bussel - Journal of Allergy and Clinical Immunology 2020 被引用: 150

  9. The ITP syndrome: pathogenic and clinical diversity

    著者: Douglas B. Cines, James B. Bussel, Howard A. Liebman, Eline T. Luning Prak - Blood 2009 被引用: 802

  10. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

    著者: David J. Kuter, James B. Bussel, Roger M. Lyons, Vinod Pullarkat, Terry Gernsheimer, Francis M. Senecal, Louis M. Aledort, James N. George, Craig M. Kessler, Miguel Á. Sanz, Howard A. Liebman, Frank T. Slovick, J. Th. M. de Wolf, Emmanuelle Bourgeois, Troy H. Guthrie, Adrian C. Newland, Jeffrey S. Wasser, Solomon I. Hamburg, Carlos Grande, François Lefrère, Alan Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean‐François Viallard, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Ding‐Ding Guo, Janet L. Nichol - The Lancet 2008 被引用: 862

  11. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn

    著者: Kenneth J. Moise, Leona E. Ling, Dick Oepkes, Eleonor Tiblad, E. J. T. Verweij, Enrico Lopriore, John Smoleniec, Ulrich J. Sachs, Gregor Bein, Mark D. Kilby, Russell S. Miller, Roland Devlieger, François Audibert, Stephen P. Emery, Kara B. Markham, Mary E. Norton, Olga Ocón‐Hernández, Pranav Pandya, Leonardo Pereira, Robert M. Silver, Rory Windrim, James B. Streisand, Jocelyn H. Leu, Arpana Mirza, Valerie Smith, Lisa Barrie Schwartz, May Lee Tjoa, Shumyla Saeed-Khawaja, Yosuke Komatsu, James B. Bussel - New England Journal of Medicine 2024 被引用: 91

  12. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

    著者: Weili Bao, James B. Bussel, Susanne Heck, Wu He, Marissa Karpoff, Nayla Boulad, Karina Yazdanbakhsh - Blood 2010 被引用: 339

  13. Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study

    著者: Raymond Wong, Mansoor N. Saleh, Abderrahim Khélif, Abdulgabar Salama, Maria Socorro O Portella, Paul Burgess, James B. Bussel - Blood 2017 被引用: 310

  14. Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program

    著者: James B. Bussel, Donald M. Arnold, Michael Boxer, Nichola Cooper, Jiřı́ Mayer, Hany Zayed, Sandra Tong, Anne‐Marie Duliège - American Journal of Hematology 2019 被引用: 120

  15. The role of CD8+ T cell clones in immune thrombocytopenia

    著者: Amna Malik, Anwar A. Sayed, Panpan Han, Michelle MH Tan, Eleanor Watt, Adela Constantinescu‐Bercu, Alexander T.H. Cocker, Ahmad Khoder, Rocel C. Saputil, Emma Thorley, Ariam Teklemichael, Yunchuan Ding, Alice C J Hart, Haiyu Zhang, Wayne Mitchell, Nesrina Imami, James T. B. Crawley, Isabelle I. Salles‐Crawley, James B. Bussel, James L. Zehnder, Stuart Adams, Bing Zhang, Nichola Cooper - Blood 2023 被引用: 54

  16. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

    著者: Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher, Sandra Y. Vasey, Bhabita Mayer, Manuel Aivado, M. Arning, Nicole L. Stone, James B. Bussel - The Lancet 2010 被引用: 582

  17. Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

    著者: Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kießling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles - Blood Advances 2020 被引用: 110

  18. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment

    著者: Oriana Miltiadous, Ming Hou, James B. Bussel - Blood 2019 被引用: 217

  19. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City

    著者: Alain Borczuk, Steven Salvatore, Surya V. Seshan, Sanjay S. Patel, James B. Bussel, Maria Mostyka, Sarah Elsoukkary, Bing He, Claudia Del Vecchio, Francesco Fortarezza, Federica Pezzuto, Paolo Navalesi, Andrea Crisanti, Mary Fowkes, Clare Bryce, Fiorella Calabrese, Mary Beth Beasley - Modern Pathology 2020 被引用: 478

  20. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

    著者: James B. Bussel, David J. Kuter, Louis M. Aledort, Craig M. Kessler, Adam Cuker, Kelly Pendergrass, Shande Tang, Joe McIntosh - Blood 2014 被引用: 162

  21. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

    著者: David J. Kuter, James B. Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard A. Liebman, Michael D. Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak - Therapeutic Advances in Hematology 2023 被引用: 32

  22. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

    著者: James B. Bussel, Gregory Cheng, Mansoor N. Saleh, Bethan Psaila, Lidia Kovaleva, Balkis Meddeb, Janusz Kłoczko, Habib Hassani, Bhabita Mayer, Nicole L. Stone, M. Arning, Drew Provan, J.M. Jenkins - New England Journal of Medicine 2007 被引用: 805

  23. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

    著者: Elisa Lucchini, Francesco Zaja, James B. Bussel - Haematologica 2019 被引用: 111

  24. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

    著者: Anna J. Podolanczuk, Alan H. Lazarus, Andrew R. Crow, Elliot Grossbard, James B. Bussel - Blood 2008 被引用: 272